Axsome Therapeutics (AXSM) Raw Materials (2022 - 2026)
Axsome Therapeutics' Raw Materials was $12.49 million in Q2 2026, up 6.6% from $11.72 million a year earlier and up 5.4% from the prior quarter.
Powered by 
Analysis
Axsome Therapeutics (AXSM) Raw Materials (2022 - 2026) Analysis & Trends
At the end of FY2025, Raw Materials at Axsome Therapeutics came in at $10.38 million, up 8.8% from FY2024.
- Raw Materials has now increased for three consecutive years, with a three-year compound annual growth rate of 61.3% (FY2022 to FY2025).
- In earlier years, Raw Materials was $9.54 million in FY2024 (+72.4%), $5.53 million in FY2023 (+123.8%) and $2.47 million in FY2022.
- The Q2 2026 figure marks the highest quarterly Raw Materials in data going back to Q3 2022.
- Compared with a year earlier, Raw Materials has increased for 12 straight quarters, with growth averaging 47.5% over the last eight quarters.
- Across the past five years, year-over-year growth in Raw Materials ran from 2.8% in Q1 2026 to 123.8% in Q4 2023.
- Per Business Quant data, AXSM's Raw Materials in the three quarters before Q2 2026 was $11.86 million (Q1 2026), $10.38 million (Q4 2025) and $12.44 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Axsome Therapeutics | 9.64 Bn | 8.37 Bn | 204.81 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.49 Mn |
| Mar 31, 2026 | 11.86 Mn |
| Dec 31, 2025 | 10.38 Mn |
| Sep 30, 2025 | 12.44 Mn |
| Jun 30, 2025 | 11.72 Mn |
| Mar 31, 2025 | 11.53 Mn |
| Dec 31, 2024 | 9.54 Mn |
| Sep 30, 2024 | 7.75 Mn |
| Jun 30, 2024 | 7.77 Mn |
| Mar 31, 2024 | 5.58 Mn |
| Dec 31, 2023 | 5.53 Mn |
| Sep 30, 2023 | 4.51 Mn |
| Jun 30, 2023 | 4.01 Mn |
| Mar 31, 2023 | 3.83 Mn |
| Dec 31, 2022 | 2.47 Mn |
| Sep 30, 2022 | 2.15 Mn |
API Access
Axsome Therapeutics Raw Materials API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=raw-materials&ticker=AXSM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "raw-materials", "ticker": "AXSM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=raw-materials&ticker=AXSM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();